Literature DB >> 18791684

Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur.

Elisa Leonardi1, Valentina Devescovi, Francesca Perut, Gabriela Ciapetti, Armando Giunti.   

Abstract

Marrow stromal cells (MSC) are increasingly being introduced in orthopaedic practice as potentially powerful effectors of bone regeneration. Since cell recovery of MSC is affected by a high degree of individual variability, sources for collecting adequate amounts of safe and effective MSC under routine conditions are needed. We analysed if femoral bone marrow, which is usually discarded during total hip arthroplasty procedures, is a reliable source of MSC to enhance bone healing and regeneration. Mononuclear cells were isolated, assayed for typical MSC markers, harvested under appropriate culture conditions and evaluated for their ability to differentiate into osteoblasts. Cell recovery and osteogenic potential were independent from donor gender or age, suggesting that elderly individuals are eligible for autologous cell therapy. Although heterogeneous, the pool of MSC recovered from femoral marrow without further in vitro selection or manipulation proved highly effective in proliferating and differentiating along the osteogenic lineage. In conclusion, this source of MSC offers a valuable tool to be used to promote osteogenesis and implant fixation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791684     DOI: 10.1007/s12306-008-0057-0

Source DB:  PubMed          Journal:  Chir Organi Mov        ISSN: 0009-4749


  43 in total

Review 1.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

2.  Selective retention of bone marrow-derived cells to enhance spinal fusion.

Authors:  George F Muschler; Yoichi Matsukura; Hironori Nitto; Cynthia A Boehm; Antonio D Valdevit; Helen E Kambic; William J Davros; Kirk A Easley; Kimerly A Powell
Journal:  Clin Orthop Relat Res       Date:  2005-03       Impact factor: 4.176

Review 3.  Mesenchymal stem cell aging.

Authors:  Christine Fehrer; Günter Lepperdinger
Journal:  Exp Gerontol       Date:  2005-08-25       Impact factor: 4.032

4.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

5.  Does the number or quality of pluripotent bone marrow stem cells decrease with age?

Authors:  Kevin Garvin; Connie Feschuk; J Graham Sharp; Ann Berger
Journal:  Clin Orthop Relat Res       Date:  2007-12       Impact factor: 4.176

6.  Circulating osteoblast-lineage cells in humans.

Authors:  Guiti Z Eghbali-Fatourechi; Jesse Lamsam; Daniel Fraser; David Nagel; B Lawrence Riggs; Sundeep Khosla
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

7.  Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering.

Authors:  G Ciapetti; L Ambrosio; G Marletta; N Baldini; A Giunti
Journal:  Biomaterials       Date:  2006-09-11       Impact factor: 12.479

8.  Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors.

Authors:  G F Muschler; H Nitto; C A Boehm; K A Easley
Journal:  J Orthop Res       Date:  2001-01       Impact factor: 3.494

Review 9.  Human bone marrow mesenchymal stem cells in vivo.

Authors:  E Jones; D McGonagle
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

10.  In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells.

Authors:  Donatella Granchi; Ilaria Amato; Luca Battistelli; Sofia Avnet; Sergio Capaccioli; Laura Papucci; Martino Donnini; Andrea Pellacani; Maria Luisa Brandi; Armando Giunti; Nicola Baldini
Journal:  Int J Cancer       Date:  2004-10-10       Impact factor: 7.396

View more
  6 in total

1.  Arthritic periosteal tissue from joint replacement surgery: a novel, autologous source of stem cells.

Authors:  Hana Chang; Denitsa Docheva; Ulf R Knothe; Melissa L Knothe Tate
Journal:  Stem Cells Transl Med       Date:  2014-01-29       Impact factor: 6.940

2.  Existence of mesenchymal stem cellsin sites of atrophic nonunion.

Authors:  H D Ismail; P Phedy; E Kholinne; Y Kusnadi; L Sandhow; M Merlina
Journal:  Bone Joint Res       Date:  2013-06-19       Impact factor: 5.853

3.  Microfracture for treatment of knee cartilage defects in children and adolescents.

Authors:  Gian M Salzmann; Bert-Ram Sah; Hagen Schmal; Philipp Niemeyer; Norbert P Sudkamp
Journal:  Pediatr Rep       Date:  2012-06-19

4.  Effects of high-mobility group a protein application on canine adipose-derived mesenchymal stem cells in vitro.

Authors:  A A Ismail; S Wagner; H Murua Escobar; S Willenbrock; K A Sterenczak; M T Samy; A M Abd El-Aal; I Nolte; P Wefstaedt
Journal:  Vet Med Int       Date:  2012-02-08

Review 5.  Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering.

Authors:  Kangkang Zha; Yue Tian; Adriana C Panayi; Bobin Mi; Guohui Liu
Journal:  Front Cell Dev Biol       Date:  2022-02-23

6.  Multidirectional percutaneous drilling and autologous bone marrow injection for the treatment of femoral diaphyseal nonunions: a prospective interventional study.

Authors:  Ming Li; Yutong Meng; Yi Li; Anhua Long; Houchen Lv; Pengbin Yin; Licheng Zhang; Peifu Tang
Journal:  Ther Clin Risk Manag       Date:  2019-08-19       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.